References
- BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin201868639442430207593
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- PanYZhangFZhaoYBerberine enhances chemosensitivity and induces apoptosis through Dose-orchestrated AMPK signaling in breast cancerJ Cancer2017891679168928775788
- MorinPJDrug resistance and the microenvironment: nature and nurtureDrug Resist Updat20036416917212962682
- Bentires-AljMDejardinEViatourPInhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell linesOncogene200120222805281311420692
- IntaIPaxianSMaegeleIBim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemiaJ Neurosci20062650128961290317167080
- SaidiSAHollandCMCharnock-JonesDSSmithSKIn vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancerMol Cancer200651316569247
- LianXGuJGaoBFenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cellsBiochem Biophys Res Commun20184961707529305864
- TaoTZhaoFXuanQShenZXiaoJShenQFenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stressBiochem Biophys Res Commun201850342685268930098788
- LiTZhangQZhangJFenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathwayBMC Cancer2014149624529079
- TsaiSCTsaiMHChiuCFAMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathwayEnviron Toxicol201631786687625545733
- HuDSuCJiangMFenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3Biochem Biophys Res Commun2016471229029526850851
- GoncalvesMDHwangSKPauliCFenofibrate prevents skeletal muscle loss in mice with lung cancerProc Natl Acad Sci U S A20181154E743E75229311302
- MuradHColletPHuin-SchohnCEffects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cellsInt J Oncol200628497798416525649
- HanDFZhangJXWeiWJFenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cellsTumour Biol20153653823382925566967
- SrinivasKPVijiRDanVMDEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinaseOncotarget2016717241542417126992219
- MiyataSWangLYKitanakaS3EZ, 20Ac-ingenol induces cell-specific apoptosis in cyclin D1 over-expression through the activation of ATR and downregulation of p-AktLeuk Res201864465129179029
- ShahMASchwartzGKCell cycle-mediated drug resistance: an emerging concept in cancer therapyClin Cancer Res2001782168218111489790
- OkonISZouMHMitochondrial ROS and cancer drug resistance: Implications for therapyPharmacol Res201510017017426276086
- HientzKMohrABhakta-GuhaDEfferthTThe role of p53 in cancer drug resistance and targeted chemotherapyOncotarget2017858921894627888811
- KusunokiMSatoDTsutsumiKTsutsuiHNakamuraTOshidaYBlack soybean extract improves lipid profiles in fenofibrate-treated type 2 diabetics with postprandial hyperlipidemiaJ Med Food201518661561825651043
- OikawaSYamashitaSNakayaNSasakiJKonoSfor the Effect of Fenofibrate and Ezetimibe Combination Treatment on Lipid (EFECTL) Study InvestigatorsEfficacy and safety of long-term coadministration of fenofibrate and ezetimibe in patients with combined hyperlipidemia: results of the EFECTL studyJ Atheroscler Thromb2017241779427397061
- Flores-CastilloCZamora-PérezJÁCarreón-TorresEAtorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand White rabbits with exogenous hypercholesterolemiaFundam Clin Pharmacol201529436237025982284
- PiwowarczykKWybieralskaEBaranJFenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cellsExpert Opin Ther Targets201519216317625389904
- GongYShaoZFuZFenofibrate inhibits cytochrome P450 epoxygenase 2C activity to suppress pathological ocular angiogenesisEBioMedicine20161320121127720395
- LianXWangGZhouHZhengZFuYCaiLAnticancer properties of fenofibrate: a repurposing useJ Cancer2018991527153729760790
- LutyMPiwowarczykKWróbelTPO-235 Fenofibrate overcomes the drug-resistance of human prostate cancer cellsESMO Open20183Suppl 2A112
- HsuSYKaipiaAMcgeeELomeliMHsuehAJBok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family membersProc Natl Acad Sci U S A1997942312401124069356461
- KeFFSVanyaiHKCowanADEmbryogenesis and adult life in the absence of intrinsic apoptosis effectors Bax, Bak, and BokCell201817351217123029775594
- BudihardjoIOliverHLutterMLuoXWangXBiochemical pathways of caspase activation during apoptosisAnnu Rev Cell Dev Biol19991526929010611963
- BenbrookDMMasamhaCPThe pro-survival function of Akt kinase can be overridden or altered to contribute to induction of apoptosisCurr Cancer Drug Targets201111558659921486222
- YangGXiaoXRosenDGThe biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancerClin Cancer Res20111782181219421339307